Clicky

Pharma Mar S.A.U.(PHMMF)

Description: Pharma Mar, S.A., a biopharmaceutical company, engages in the discovery and development of marine-derived anticancer drugs in Spain and internationally. The company operates through two segments, Biopharmaceuticals and Consumer Chemicals. It develops and commercializes Yondelis, an antitumor agent for the treatment of advanced soft tissue sarcomas and for relapsed ovarian cancer. The company also develops clinical-stage programs, including Aplidin, Lurbinectedin, PM184, and PM14. In addition, it develops and provides diagnostics kit for genetic diagnostics and DNA analysis; and produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Pharma Mar, S.A. was founded in 1986 and is based in Madrid, Spain.


Keywords: Biopharmaceutical Organic Compounds Chemical Compounds Household Products Ovarian Cancer Insecticide Phenols Sarcoma Air Freshener Coma Decoration Products Soft Tissue Sarcoma Insect Soft Tissue Sarcomas Trabectedin

Home Page: www.pharmamar.com

Avenida de los Reyes, 1
Madrid, 28770
Spain
Phone: 34 91 846 60 00


Officers

Name Title
Mr. Jose Maria Fernandez Sousa-Faro Founder, Exec. Chairman, CEO & Pres
Mr. Pedro Francisco Fernandez Puentes Exec. Vice-Chairman
Mr. Juan Carlos-Torres Carretero Founder
Ms. María Luisa de Francia Caballero Chief Financial Officer
Ms. Elena Calleja Crespo Director of Fin. & Admin.
Mr. José Luis Moreno Martinez-Losa Director of Capital Markets & Investor Relations
Mr. Juan Gomez Pulido Gen. Counsel & Sec. of the Board of Directors
Ms. Sandra Llamera Sanchez Global Compliance Head
Ms. Lara Vadillo Communication Director
Mr. Juan Nogues Director of International Marketing & Sales

Exchange: PINK

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 13.9228
Price-to-Book MRQ: 5.6047
Price-to-Sales TTM: 5.5667
IPO Date:
Fiscal Year End: December
Full Time Employees: 477
Back to stocks